Efient - Drug Insight, 2018 - ResearchAndMarkets.com

December 27, 2018

DUBLIN--(BUSINESS WIRE)--Dec 27, 2018--The “Efient - Drug Insight, 2018” drug pipelines has been added to ResearchAndMarkets.com’s offering.

‘Efient Drug Insight, 2018’ highlights the drug marketed details and the Global API Manufacturers details across the globe, along with the location.

The report covers the Global Market Assessment of Efient, covering historical global sales and also provides the Efient sales estimation during the forecast period (2018-2020).

The report also covers the patents information and market exclusivity data, route of synthesis, market competition, and API manufacturers by country. In addition to this, the report also provides the SWOT analysis for Efient and emerging therapies in this space.


A review of the Efient, based on information derived from company and industry-specific sources Product details on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification Coverage of the Drug Master Files and API Manufacturers by country Patent Expiry Timeline and Exclusivity Details Route of Synthesis of the API Forecasted Sales Figure from 2018-2020 Market competition and emerging therapies SWOT Analysis

Key Topics Covered

1. Introduction

2. Efient - Overview

Product Description Route of Synthesis Mechanism of Action Pharmacology Pharmacodynamics Pharmacokinetics Adverse Reactions Regulatory Milestones by Region Deals and Partnerships

3. Product Details

4. Efient Sales Assessment

Historical Sales Forecasted Sales

5. Patent Details

6. Global API Manufacturers Assessment

Active Pharmaceutical Ingredient (API) Manufacturers by Country Active Pharmaceutical Ingredient (API) Manufacturers by Region

7. Market Competition

8. Emerging Therapies

8.1 Drug 1: Company 1

Product Description Research and Development Product Development Activities

9. SWOT Analysis

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/cr66tl/efient_drug?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181227005152/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Cardiovascular Drugs



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 12/27/2018 06:18 AM/DISC: 12/27/2018 06:18 AM


Update hourly